{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:09:36Z","timestamp":1771589376796,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"DOI":"10.7759\/cureus.103956","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:26:14Z","timestamp":1771586774000},"source":"Crossref","is-referenced-by-count":0,"title":["Self-Referred Late-Onset Hypogonadism Hypothesis and Testosterone Replacement Therapy in Major Depressive Disorder Under Polypharmacy: A Case Report"],"prefix":"10.7759","author":[{"given":"Kenta","family":"Ichino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Okui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisamitsu","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.10.010","article-title":"Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study","volume":"172","author":"Fried EI","year":"2015","unstructured":"Fried EI, Nesse RM. Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study. J Affect Disord. 2015, 172:96-102. 10.1016\/j.jad.2014.10.010","journal-title":"J Affect Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2015.00309","article-title":"Problematic assumptions have slowed down depression research: why symptoms, not syndromes are the way forward","volume":"6","author":"Fried EI","year":"2015","unstructured":"Fried EI. Problematic assumptions have slowed down depression research: why symptoms, not syndromes are the way forward. Front Psychol. 2015, 6:309. 10.3389\/fpsyg.2015.00309","journal-title":"Front Psychol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0325-4","article-title":"Depression sum-scores don't add up: why analyzing specific depression symptoms is essential","volume":"13","author":"Fried EI","year":"2015","unstructured":"Fried EI, Nesse RM. Depression sum-scores don't add up: why analyzing specific depression symptoms is essential. BMC Med. 2015, 13:72. 10.1186\/s12916-015-0325-4","journal-title":"BMC Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.02.023","article-title":"The identification, assessment and management of difficult-to-treat depression: an international consensus statement","volume":"267","author":"McAllister-Williams RH","year":"2020","unstructured":"McAllister-Williams RH, Arango C, Blier P, et al.. The identification, assessment and management of difficult-to-treat depression: an international consensus statement. J Affect Disord. 2020, 267:264-82. 10.1016\/j.jad.2020.02.023","journal-title":"J Affect Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1198437","article-title":"The association of hypogonadism with depression and its treatments","volume":"14","author":"Indirli R","year":"2023","unstructured":"Indirli R, Lanzi V, Arosio M, Mantovani G, Ferrante E. The association of hypogonadism with depression and its treatments. Front Endocrinol (Lausanne). 2023, 14:1198437. 10.3389\/fendo.2023.1198437","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12867","article-title":"Testosterone, mood, behaviour and quality of life","volume":"8","author":"Zitzmann M","year":"2020","unstructured":"Zitzmann M. Testosterone, mood, behaviour and quality of life. Andrology. 2020, 8:1598-605. 10.1111\/andr.12867","journal-title":"Andrology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.122336","article-title":"Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment","volume":"16","author":"Huhtaniemi I","year":"2014","unstructured":"Huhtaniemi I. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl. 2014, 16:192-202. 10.4103\/1008-682X.122336","journal-title":"Asian J Androl"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/iju.15160","article-title":"Summary of the clinical practice manual for late-onset hypogonadism","volume":"30","author":"Ide H","year":"2023","unstructured":"Ide H, Akehi Y, Fukuhara S, et al.. Summary of the clinical practice manual for late-onset hypogonadism. Int J Urol. 2023, 30:422-30. 10.1111\/iju.15160","journal-title":"Int J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-022-09763-4","article-title":"Diagnosis of hypogonadism in ageing men","volume":"23","author":"Kaufman JM","year":"2022","unstructured":"Kaufman JM. Diagnosis of hypogonadism in ageing men. Rev Endocr Metab Disord. 2022, 23:1139-50. 10.1007\/s11154-022-09763-4","journal-title":"Rev Endocr Metab Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society Clinical Practice Guideline","volume":"103","author":"Bhasin S","year":"2018","unstructured":"Bhasin S, Brito JP, Cunningham GR, et al.. Testosterone therapy in men with hypogonadism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018, 103:1715-44. 10.1210\/jc.2018-00229","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2022.2049753","article-title":"Sexual dysfunction with major depressive disorder and antidepressant treatments: impact, assessment, and management","volume":"21","author":"Winter J","year":"2022","unstructured":"Winter J, Curtis K, Hu B, Clayton AH. Sexual dysfunction with major depressive disorder and antidepressant treatments: impact, assessment, and management. Expert Opin Drug Saf. 2022, 21:913-30. 10.1080\/14740338.2022.2049753","journal-title":"Expert Opin Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3233\/JRS-210023","article-title":"Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin","volume":"33","author":"Healy D","year":"2022","unstructured":"Healy D, Bahrick A, Bak M, et al.. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. Int J Risk Saf Med. 2022, 33:65-76. 10.3233\/JRS-210023","journal-title":"Int J Risk Saf Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2022.2071124","article-title":"Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment","volume":"23","author":"Jannini TB","year":"2022","unstructured":"Jannini TB, Sansone A, Rossi R, Di Lorenzo G, Toscano M, Siracusano A, Jannini EA. Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment. Expert Opin Pharmacother. 2022, 23:1065-80. 10.1080\/14656566.2022.2071124","journal-title":"Expert Opin Pharmacother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall JP","year":"2018","unstructured":"Mulhall JP, Trost LW, Brannigan RE, et al.. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018, 200:423-32. 10.1016\/j.juro.2018.03.115","journal-title":"J Urol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41443-023-00709-1","article-title":"Trends in testosterone prescription during the release of society guidelines","volume":"36","author":"Sellke N","year":"2024","unstructured":"Sellke N, Omil-Lima D, Sun HH, Tay K, Rhodes S, Loeb A, Thirumavalavan N. Trends in testosterone prescription during the release of society guidelines. Int J Impot Res. 2024, 36:380-4. 10.1038\/s41443-023-00709-1","journal-title":"Int J Impot Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2020.760","article-title":"Current national and international guidelines for the management of male hypogonadism: helping clinicians to navigate variation in diagnostic criteria and treatment recommendations","volume":"35","author":"Al-Sharefi A","year":"2020","unstructured":"Al-Sharefi A, Quinton R. Current national and international guidelines for the management of male hypogonadism: helping clinicians to navigate variation in diagnostic criteria and treatment recommendations. Endocrinol Metab (Seoul). 2020, 35:526-40. 10.3803\/EnM.2020.760","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2024.04.009","article-title":"Association of 5\u03b1-reductase inhibitors with depression and suicide: a mini systematic review and meta-analysis","volume":"10","author":"Uleri A","year":"2024","unstructured":"Uleri A, Nicolas Cornu J, Gobbo A, Herrmann TR, De Nunzio C, Hashim H, Baboudjian M. Association of 5\u03b1-reductase inhibitors with depression and suicide: a mini systematic review and meta-analysis. Eur Urol Focus. 2024, 10:751-3. 10.1016\/j.euf.2024.04.009","journal-title":"Eur Urol Focus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.70579","article-title":"Finasteride use does not lead to depression or suicide: insights from a large-scale cohort study and Mendelian randomization analysis","volume":"24","author":"Wang J","year":"2025","unstructured":"Wang J, Lin D, Zhao J, Wei S, Wang H, Li W. Finasteride use does not lead to depression or suicide: insights from a large-scale cohort study and Mendelian randomization analysis. J Cosmet Dermatol. 2025, 24:e70579. 10.1111\/jocd.70579","journal-title":"J Cosmet Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jhrm.21456","article-title":"Do my feelings fit the diagnosis? Avoiding misdiagnoses in psychosomatic consultation services","volume":"41","author":"Seidl E","year":"2021","unstructured":"Seidl E, Seidl O. Do my feelings fit the diagnosis? Avoiding misdiagnoses in psychosomatic consultation services. J Healthc Risk Manag. 2021, 41:9-17. 10.1002\/jhrm.21456","journal-title":"J Healthc Risk Manag"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2018.07.006","article-title":"Systematic review of the impact of testosterone replacement therapy on depression in patients with late-onset testosterone deficiency","volume":"6","author":"Vartolomei MD","year":"2020","unstructured":"Vartolomei MD, Kimura S, Vartolomei L, Shariat SF. Systematic review of the impact of testosterone replacement therapy on depression in patients with late-onset testosterone deficiency. Eur Urol Focus. 2020, 6:170-7. 10.1016\/j.euf.2018.07.006","journal-title":"Eur Urol Focus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464027-self-referred-late-onset-hypogonadism-hypothesis-and-testosterone-replacement-therapy-in-major-depressive-disorder-under-polypharmacy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:26:15Z","timestamp":1771586775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464027-self-referred-late-onset-hypogonadism-hypothesis-and-testosterone-replacement-therapy-in-major-depressive-disorder-under-polypharmacy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.103956","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,20]]}}}